DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20215053

The pattern of distant metastasis and clinicopathological factors associated with de-novo metastatic cervical cancer: a retrospective analysis

J. Kannan, Amit Saklani, Srigopal Mohanty, Kiranmayee Narapaneni, Deepak George, N. Ingersal

Abstract


Background: Metastatic cervical cancer carries poor prognosis. The factors associated with distant metastasis in newly diagnosed cervical cancer patients are not clear.

Methods: A retrospective analytical study was performed to study the pattern of distant metastasis, and to evaluate the factors associated with de-novo metastatic cervical cancer. Univariate and multivariate analysis (by MANOVA) were used to evaluate the association. P≤0.05 was considered significant.

Results: Out of 1321 newly diagnosed cervical cancer patients, 54 (4.1%) had de-novo metastatic disease and most of which (81%) were found at single site. Common sites of distant metastasis were non-regional nodes, followed by liver, lung, peritoneum and bone. Univariate analysis showed the factors associated with de-novo metastasis were non squamous subtype, high grade histology, bulky primary tumor (>4 cm), pelvic/para-aortic lymphadenopathy, and hydroureteronephrosis. Multivariate analysis revealed the factors associated with de-novo metastasis were bulky primary tumor (>4 cm), high grade histology, pelvic/para aortic lymphadenopathy, hydroureteronephrosis.

Conclusions: Newly diagnosed cervical cancer patients with bulky primary tumor, high grade histology, pelvic or para aortic lymphadenopathy, hydroureteronephrosis are associated with higher risk of de-novo distant metastasis.


Keywords


Cervical cancer, Distant metastasis, Pattern, risk factors

Full Text:

PDF

References


Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.

Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian J Med Paediatric Oncol. 2016;37(4):278-85.

World health Organization (WHO). International Agency for Research on Cancer. India factsheet. Lyon: IARC; 2018. Available at: https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf. Accessed on 25 August 2021.

Monica, Mishra R. An epidemiological study of cervical and breast screening in India: district level analysis. BMC Women’s Health. 2020;20:225.

Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, et al. ICMR-NCDIR-NCRP investigator group. Cancer statistics 2020: reports from national cancer registry programme, India. J Glob Oncol. 2020;6:1063-75.

Ramkumar B, Mohanty S, Narapaneni K, Saklani A, Kannan J. Cervical cancer among 39 years or younger females in south India; a retrospective study. Int J Sci Res. 2021;10(7):15-7.

Dunyo P, Effah K, Udofia EA. Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study. BMC Public Health. 2018;18(1):1156.

Shankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. 2009;360(14):1385-94.

Thulaseedharan JV, Frie KG, Samkaranarayanan R. Challenges of health promotion and education strategies to prevent cervical cancer in India: a systematic review. J Educ Health Promot. 2019;8:216.

Bhatla N, Aoki D, Sharma DN, Shankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(2):22-36.

Chuang LT, Temin S, Camacho R, Duaenas-Gonzalez D, Feldman S, Gultekin M, et al. Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource stratified clinical practice guideline. J Glob Oncol. 2016;2(5):311-40.

Petignat P, Roy M. Diagnosis and management of cervical cancer. BMJ. 2007;335 (7623):765-8.

Scatchard K, Forrest JL, Flubacher M, Cornes P, Williams C. Chemotherapy for metastatic and recurrent cervical cancer. Cochrane Database Syst Rev. 2012;10(10):CD006469.

Tewari KS, Sill MW, Long HJ, Penson RT, Huang H, Ramondetta LM, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370:734-43.

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374-403.

Zhou S, Peng F. Patterns of metastases in cervical cancer: a population based study. Int J Clin Exp Pathol. 2020;13(7):1615-23.

Yin Z, Tang H, Li L, Ni J, Yuan S, Lou H, Chen M. Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer. Cancer Manag Res. 2019;11:7759-66.

Zhang Y, Guo Y, Zhou X, Wang X, Wang X. Prognosis for different patterns of distant metastases in patients with uterine cervical cancer: a population based analysis. J Cancer. 2020;11(6):1532-41.

Liu X, Meng Q, Wang W, Zhou Z, Zhang F, Hu K. Predictors of distant metastasis in patients with cervical cancer treated with definitive radiotherapy. J cancer. 2019;10(17):3967-74.

Wang W, Liu X, Meng Q, Zhang F, Hu K. Normogram predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases. PLoS one. 2019;14(4):e0214498.

Cheng S, Li Y, Zhang M, Tong T. PET/CT imaging analysis of recurrent sites and patterns of spread following modified radical surgery (type B) for stage Ib-IIa cervical cancer. Oncol letters. 2018;16(3):3623-27.

Stock RG, Chen AS, Karasek K. Patterns of spread in node positive cervical cancer: the relationship between local control and distant metastases. Cancer J Sci Am. 1996;2(5):256-62.

Fortin I, Jurgenliemk-Schulz I, Mahantshetty U, Haie-Meder C, Hoskin P, Segedin B, et al. Distant metastases in locally advanced cervical cancer pattern of relapse and prognostic factors: early results from the EMBRACE study. Int J radiat Oncol Biol Phys. 2015;93(3):S8-9.